NEW YORK (GenomeWeb) – San Diego-based startup OnSiteGene is developing an ultra-fast molecular diagnostics platform that can perform highly multiplexed real-time PCR assays in about five minutes. The firm plans to build on the throughput and multiplexing capabilities of its instrument to develop customizable syndromic infectious disease panels, allowing users to select which molecular tests to run for each patient sample.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.